AK
Aziz Kabeer
Director
BoardM
Insider track record
Board DirectorAcross 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Explore the full record of transactions filed by Aziz Kabeer, Director. Officer active across 1 company, notably AN2 Therapeutics, Inc.. Aggregated, 19 reports have been logged. Breakdown: 0 buy · 10 sells. Total volume traded: €3.2m. Activity tracked since 6 June 2022. The latest transaction was disclosed on 10 July 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations19 total
2,852 shares0Common StockSEC:0001193125-26-301167:0
3,775 shares0Common StockSEC:0001193125-26-151632:0
11,560 shares0Common StockSEC:0001193125-26-013041:0
10,367 shares0Common StockSEC:0001193125-25-238983:0
11,875 shares0Common StockSEC:0000950170-25-095408:0
9,705 shares0Common StockSEC:0000950170-25-053367:0
8,972 shares0Common StockSEC:0000950170-24-139800:0
84,093 shares@ US$19.6542.1% of flowCommon StockSEC:0000950170-24-005515:0
1,522 shares@ US$16.1460.6% of flowCommon StockSEC:0000950170-23-064609:0
83,337 shares@ US$16.2835.8% of flowCommon StockSEC:0000950170-23-051733:0
15,764 shares@ US$16.286.8% of flowCommon StockSEC:0000950170-23-051733:1
4,770 shares@ US$16.072.0% of flowCommon StockSEC:0000950170-23-051733:2
902 shares@ US$16.070.4% of flowCommon StockSEC:0000950170-23-051733:3
707 shares@ US$16.072.5% of flowCommon StockSEC:0000950170-23-050851:0
336 shares@ US$16.000.1% of flowCommon StockSEC:0000950170-23-048436:0
3,164 shares@ US$16.021.3% of flowCommon StockSEC:0000950170-23-047311:0
336 shares@ US$16.000.1% of flowCommon StockSEC:0000950170-23-044593:0
26,511 shares@ US$15.000.23% mcap100.0% of flowCommon StockSEC:0000899243-22-024054:0
1,651,636 sharesCommon StockSEC:0000899243-22-012988:0
About Aziz Kabeer
Aziz Kabeer serves as a Director at AN2 Therapeutics, Inc. As a board member, he participates in overseeing the company's operations and making strategic decisions. His experience in the sector contributes to guiding management in achieving the company's objectives. He plays a key role in corporate governance and performance evaluation.